{"id":24512,"date":"2022-11-09T18:38:00","date_gmt":"2022-11-09T10:38:00","guid":{"rendered":"https:\/\/flcube.com\/?p=24512"},"modified":"2025-01-31T18:47:21","modified_gmt":"2025-01-31T10:47:21","slug":"yibao-technology-secures-series-a-funding-to-expand-health-insurance-services","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=24512","title":{"rendered":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services"},"content":{"rendered":"\n<p>Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (&#8220;Huiminbao&#8221;) schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical &amp; Pharmaceutical Co., Ltd. Existing investors BioTrack Capital, Eight Roads, and Marathon Venture Partners also participated.<\/p>\n\n\n\n<p><strong>Urban Health Security Platform Development<\/strong><br>In conjunction with the funding, Yibao Technology and CR Pharma will develop an &#8220;urban health security platform.&#8221; This platform is designed to promote health insurance and access to novel medicines, and to facilitate the construction of a multi-layered healthcare security system. This initiative aligns with China&#8217;s &#8220;14th Five-Year Plan Universal Healthcare Security Plan,&#8221; which was released in September 2021 and outlines government plans to support the Basic Medical Insurance (BMI) system through the development of the commercial health insurance sector, including supplementary Huiminbao schemes.<\/p>\n\n\n\n<p><strong>Business Presence and Future Plans<\/strong><br>By the end of 2021, there were over 200 Huiminbao-covered medical products across 27 provinces in China, with 140 million citizens participating in the schemes. Yibao&#8217;s business covers over 50 cities and 25 million insurance participants. The partnership with CR Pharma will enhance patient access to healthcare security services, including medicines, and explore solutions for Huiminbao drugs, chronic disease medications, chronic disease screening, and innovative payment schemes for medicines.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (&#8220;Huiminbao&#8221;) schemes,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1975,20,595,3442],"class_list":["post-24512","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-china-resources-pharmaceutical","tag-finance","tag-private-health-care-insurance","tag-yibao-technology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (&quot;Huiminbao&quot;) schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical &amp; Pharmaceutical Co., Ltd. Existing investors BioTrack Capital, Eight Roads, and Marathon Venture Partners also participated.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=24512\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=24512\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-09T10:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-31T10:47:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services\",\"datePublished\":\"2022-11-09T10:38:00+00:00\",\"dateModified\":\"2025-01-31T10:47:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512\"},\"wordCount\":237,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"China Resources Pharmaceutical\",\"Finance\",\"Private health care \\\/ insurance\",\"Yibao Technology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24512#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=24512\",\"name\":\"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-11-09T10:38:00+00:00\",\"dateModified\":\"2025-01-31T10:47:21+00:00\",\"description\":\"Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (\\\"Huiminbao\\\") schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Existing investors BioTrack Capital, Eight Roads, and Marathon Venture Partners also participated.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=24512\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=24512#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services - Insight, China&#039;s Pharmaceutical Industry","description":"Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (\"Huiminbao\") schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Existing investors BioTrack Capital, Eight Roads, and Marathon Venture Partners also participated.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=24512","og_locale":"en_US","og_type":"article","og_title":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=24512","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-11-09T10:38:00+00:00","article_modified_time":"2025-01-31T10:47:21+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=24512#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=24512"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services","datePublished":"2022-11-09T10:38:00+00:00","dateModified":"2025-01-31T10:47:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=24512"},"wordCount":237,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["China Resources Pharmaceutical","Finance","Private health care \/ insurance","Yibao Technology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=24512#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=24512","url":"https:\/\/flcube.com\/?p=24512","name":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-11-09T10:38:00+00:00","dateModified":"2025-01-31T10:47:21+00:00","description":"Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (\"Huiminbao\") schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Existing investors BioTrack Capital, Eight Roads, and Marathon Venture Partners also participated.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=24512#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=24512"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=24512#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=24512"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24512\/revisions"}],"predecessor-version":[{"id":24514,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/24512\/revisions\/24514"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=24512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=24512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=24512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}